A detailed history of Callodine Capital Management, LP transactions in Sanofi stock. As of the latest transaction made, Callodine Capital Management, LP holds 364,189 shares of SNY stock, worth $17.4 Million. This represents 4.9% of its overall portfolio holdings.

Number of Shares
364,189
Previous 379,189 3.96%
Holding current value
$17.4 Million
Previous $18.4 Million 14.14%
% of portfolio
4.9%
Previous 4.66%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$48.54 - $58.53 $728,100 - $877,950
-15,000 Reduced 3.96%
364,189 $21 Million
Q2 2024

Aug 13, 2024

BUY
$45.39 - $50.36 $453,900 - $503,600
10,000 Added 2.71%
379,189 $18.4 Million
Q1 2024

May 14, 2024

BUY
$45.75 - $52.48 $3.17 Million - $3.63 Million
69,189 Added 23.06%
369,189 $17.9 Million
Q4 2023

Feb 14, 2024

BUY
$43.13 - $54.79 $2.37 Million - $3.01 Million
55,000 Added 22.45%
300,000 $14.9 Million
Q3 2023

Nov 13, 2023

SELL
$50.95 - $55.2 $764,250 - $828,000
-15,000 Reduced 5.77%
245,000 $13.1 Million
Q2 2023

Aug 14, 2023

SELL
$50.45 - $57.18 $4.29 Million - $4.86 Million
-85,000 Reduced 24.64%
260,000 $14 Million
Q1 2023

May 12, 2023

SELL
$45.86 - $54.45 $229,300 - $272,250
-5,000 Reduced 1.43%
345,000 $18.8 Million
Q4 2022

Feb 13, 2023

BUY
$38.86 - $48.55 $1.94 Million - $2.43 Million
50,000 Added 16.67%
350,000 $17 Million
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $4.95 Million - $13.4 Million
133,065 Added 79.71%
300,000 $11.4 Million
Q2 2022

Aug 12, 2022

BUY
$48.99 - $57.46 $8.18 Million - $9.59 Million
166,935 New
166,935 $8.35 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Callodine Capital Management, LP Portfolio

Follow Callodine Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callodine Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Callodine Capital Management, LP with notifications on news.